In the progression of cancer, HSPA5 is translocated to the cell surface (csHSPA5) where it activates key signaling pathways, such as the PI3K/AKT and MAPK/ERK signaling pathways, which promote cell survival and inhibit apoptosis14-19. This evidence concerns the gene AKT1 and cancer.